Centene Corporation filings document operating and financial disclosures for a government-focused managed care company. Form 8-K reports furnish quarterly results press releases, GAAP and adjusted EPS guidance, non-GAAP financial measure disclosures, conference-related Regulation FD updates and material-event reports tied to company performance.
Centene's proxy and governance filings cover annual meeting matters, board and executive compensation disclosures, equity awards, officer appointments and related corporate governance topics. Other filings address material agreements, forward-looking-statement disclosures and formal exhibits filed or furnished with the SEC.
CENTENE CORP (CNC) reports that management will present at the Deutsche Bank 2026 Healthcare Summit on September 16, 2026, and in related investor discussions will reaffirm full-year 2026 earnings guidance, including GAAP diluted EPS of greater than $3.11 and adjusted diluted EPS of greater than $4.80.
The company explains that it uses non-GAAP measures, such as adjusted diluted EPS, to evaluate performance, plan operations, and determine incentive compensation, and it directs investors to a prior July 28, 2026 press release for reconciliations. The guidance is characterized as forward-looking and is stated to be effective only through September 25, 2026, with no obligation to update except as may be required by law. Extensive risk factors are outlined that could cause actual results to differ from this guidance.
CENTENE CORP (CNC) insider Christopher Koster, Secretary & General Counsel, reported selling 56,500 shares of common stock on 2026-08-26 in an open-market or private transaction at a weighted average price between $66.90 and $66.91. After this sale, he directly holds 248,853.991 shares, including 229,874 restricted stock units and performance stock units reported at target performance and subject to vesting requirements. He also reports 100 shares of indirect ownership held by his spouse. The transactions were not affirmed as being under a Rule 10b5-1 trading plan.
Centene Corp.'s former director Kenneth A. Burdick reported an intended sale of 43,600 common shares, with an approximate sale date of August 26, 2026, and an aggregate market value of $2,834,000. The shares were acquired through restricted stock vesting from the issuer on February 6, 2024.
Burdick also reported an intention to write 200 covered call options at a $70 strike price, expiring November 20, 2026; 200 at $75 and 36 at $80, both groups expiring December 18, 2026. His reported sales in the preceding three months were 80,000 shares on June 10, 2026, for gross proceeds of $5,164,227.15, and 100,000 shares on August 5, 2026, for $6,815,181.65.
CENTENE CORP (CNC) received a Rule 144 notice covering a proposed sale of up to 56,500 shares of its common stock for the account of officer Christopher A. Koster, through Fidelity Brokerage Services LLC. The stated aggregate market value of the shares covered is $3,779,852.00 as of August 26, 2026, with 493,995,000 shares of common stock outstanding.
The shares derive from multiple acquisitions between 2020 and 2025, including employee stock purchase plan (ESPP) purchases and restricted stock vesting awards. The filing also reports that Koster sold 47,603 shares of Centene common stock on August 18, 2026 for $3,111,262.14.
CENTENE CORP (CNC) reported that officer Christopher Koster, Secretary & General Counsel, sold 47,603 shares of common stock on 2026-08-18 in an open-market transaction at a weighted average price of $65.36 per share, with individual sale prices ranging from $65.28 to $65.45. Following this sale, his reported direct ownership is 305,353.991 shares, which includes common stock acquired through the company’s Employee Stock Purchase Program and 229,874 shares of previously granted restricted stock units and performance stock units at target performance, all subject to vesting requirements. An additional 100 shares are reported as indirectly owned by his spouse.
CENTENE CORP (CNC) received a notice under Rule 144 that officer Christopher A. Koster, through Fidelity Brokerage Services LLC, may sell 47,603 shares of Centene common stock on the NYSE. The filing lists an aggregate market value of $3,111,262.14 for these shares and indicates 493,995,000 shares outstanding as of 08/18/2026. The shares derive from multiple restricted stock vesting events granted as compensation between December 2021 and February 2024.
Centene Corporation announced a planned Chief Financial Officer transition and reaffirmed its 2026 outlook. Current CFO Drew (Andrew) Asher plans to retire as CFO effective December 31, 2026 and will serve as Strategic Advisor to CEO Sarah M. London through the end of 2027 to support strategic initiatives and an orderly handover.
The company has entered into an employment agreement with Christopher Neczypor, who will join around September 1, 2026 as Executive Vice President and is intended to become Executive Vice President and CFO on January 1, 2027. His package includes a $1.1 million base salary, target annual cash bonus of 150% of salary (capped at 200% of target), and eligibility for $5.25 million in annual long-term equity awards starting in 2027, plus $10 million in make-whole restricted stock units and a $2 million cash sign-on bonus, subject to a one-year clawback condition. Centene reaffirmed its previously issued full-year 2026 adjusted diluted EPS guidance of greater than $4.80 and all related 2026 guidance metrics. The company highlighted revenue growth from approximately $126 billion in 2021 to approximately $195 billion in 2025 during Asher’s tenure as CFO.
A holder of CNC common stock filed a notice of proposed sales under Rule 144. The notice covers up to 100,000 shares of common stock to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $6,815,181.65 and 493,995,000 common shares outstanding, as of the filing. The document lists prior equity awards from restricted stock vesting and notes that Kenneth Burdick sold 80,000 common shares for $5,164,227.15 on June 10, 2026.
Centene Corporation is undertaking a partial redemption of its outstanding 4.25% Notes due December 15, 2027, covering $500,000,000 aggregate principal amount. The redemption is scheduled to occur on August 13, 2026, in accordance with the terms of the notes and the governing indenture.
Following completion, approximately $568,664,000 of the 2027 Notes will remain outstanding. The redemption price will equal 100% of the principal amount of notes being redeemed plus accrued and unpaid interest to, but excluding, the redemption date, and this communication does not constitute a formal notice of redemption with respect to the 2027 Notes.
Centene Corp director Paul J. Diaz reported an equity compensation award of 2,771 restricted stock units, recorded as a grant/award acquisition of common stock at a stated price of $0.0000 per share. According to the award terms, all 2,771 units will vest in full at Centene’s 2027 annual meeting of stockholders, after which the underlying shares become fully earned. Following this transaction, Diaz’s directly reported common stock holdings stand at 2,771 shares.